We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 140 results
  1. Evidence of Selective Interaction of Nerve Growth Factor Dipeptide Mimetic GK-2 with TrkA Receptor Using TrkA and TrkB Knockout HT-22 Cells

    TrkA and TrkB knockout HT-22 cell lines were used to prove that the neuroprotective properties of GK-2 [ bis ( N -monosuccinyl- L -glutamyl- L -lysine...

    T. A. Antipova, I. E. Deev, ... S. B. Seredenin in Pharmaceutical Chemistry Journal
    Article 18 March 2023
  2. Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies

    The desire to find a gold-standard therapy for depression is still ongoing. Develo** one universal and effective pharmacotherapy remains...

    Barbara Chruścicka-Smaga, Agata Machaczka, ... Andrzej Pilc in Pharmacological Reports
    Article Open access 07 November 2023
  3. The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice

    Background

    Our earlier studies have shown that the brain noradrenergic system regulates cytochrome P450 (CYP) in rat liver via neuroendocrine...

    Ewa Bromek, Przemysław Jan Danek, ... Władysława Anna Daniel in Pharmacological Reports
    Article Open access 26 August 2022
  4. Ventricular arrhythmias, antiarrhythmic therapy and thyroidal illness in advanced heart failure: a case report and review of the literature

    Ventricular arrhythmias are common and can modify the risk profile in patients with advanced heart failure. Guideline-directed medical therapy as...

    Fatima Alsalama, Salma Alzaabi, ... Bassam Atallah in Drugs & Therapy Perspectives
    Article 02 March 2023
  5. KM-408, a novel phenoxyalkyl derivative as a potential anticonvulsant and analgesic compound for the treatment of neuropathic pain

    Background

    Epilepsy frequently coexists with neuropathic pain. Our approach is based on the search for active compounds with multitarget profiles...

    Anna Waszkielewicz, Henryk Marona, ... Elżbieta Wyska in Pharmacological Reports
    Article Open access 19 November 2022
  6. Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms

    Second-generation antipsychotics are widely used for the treatment of schizophrenia. Aripiprazole (ARI) is classified as a third-generation...

    Adriana Stelmach, Katarzyna Guzek, ... Anna Sadakierska-Chudy in Pharmacological Reports
    Article Open access 16 December 2022
  7. Cyclosporin A Enhance the Cytotoxicity of Immunotoxin to the HER-2-Overexpressing SK-OV-3 Cells: A Prospective Study

    This study explores the synergistic effect of T-CUS 245C combined with cyclosporin A, and its possible mechanism. T-CUS 245C is an immunotoxin...

    Huilong **e, Yunrong Fu, ... Jieming **e in Revista Brasileira de Farmacognosia
    Article 08 May 2024
  8. Cannabinoids and their derivatives in struggle against melanoma

    Abstract

    Melanoma is one of the most aggressive malignances in human. Recently developed therapies improved overall survival rate, however, the...

    Paweł Marzęda, Małgorzata Drozd, ... Jarogniew J. Łuszczki in Pharmacological Reports
    Article Open access 15 July 2021
  9. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics

    Proton pump inhibitors (PPIs) are the most commonly prescribed drugs for the treatment of non-erosive reflux disease (NERD), ulcers associated with...

    Aneta Kiecka, Marian Szczepanik in Pharmacological Reports
    Article Open access 04 May 2023
  10. The role of mucosal barriers in human gut health

    The intestinal mucosa is continuously exposed to a large number of commensal or pathogenic microbiota and foreign food antigens. The intestinal...

    Kangseok Seo, Jeongmi Seo, ... Sun-Young Chang in Archives of Pharmacal Research
    Article 22 April 2021
  11. A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease

    Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the central nervous system (CNS) leading to mental deterioration and...

    Karolina Maciejewska, Kamila Czarnecka, Paweł Szymański in Pharmacological Reports
    Article Open access 13 June 2021
  12. Signaling pathways underlying changes in the contractility of the stomach fundus smooth muscle in diabetic rats

    Dysfunction of gastrointestinal (GI) motility is a common complication in patients with diabetes mellitus (DM). Studies related to changes in fundus...

    Dong Min Kim, Tin Myo Khing, ... Uy Dong Sohn in Archives of Pharmacal Research
    Article 30 June 2020
  13. Antidepressant-like effects of kynurenic acid in a modified forced swim test

    Background

    Kynurenic acid (KYNA) is an l -tryptophan metabolite with neuromodulatory activities, regulating the release of neurotransmitters such as...

    Masaru Tanaka, Zsuzsanna Bohár, ... László Vécsei in Pharmacological Reports
    Article Open access 12 March 2020
  14. Recent and updated pharmacotherapy of migraine

    Migraine is a complex and still debatable neurovascular disorder that is on the rise globally, affecting patients of all ages. Various drugs are...

    Alok Singh, Pugazhenthan Thangaraju, Suryaprakash Dhaneria in Drugs & Therapy Perspectives
    Article 08 August 2019
  15. Pharmacogenetic Tests for Antipsychotic-Induced Weight Gain

    Second-generation antipsychotic substances, as compared with first-generation antipsychotics, are more effective in relation to psychotic symptoms...

    E. O. Zhuravleva, N. Yu. Vel’ts, ... R. N. Alyautdin in Pharmaceutical Chemistry Journal
    Article 01 October 2019
  16. Significant reduction of vascular reactivity with dantrolene and nimodipine in diabetic rats: a potential approach to cerebral vasospasm management in diabetes

    Background

    Diabetics have a higher risk of develo** cerebral vasospasms (CVSPs) than non-diabetics. Current therapies are ineffective in reducing...

    Marie Román, José M. Ramírez, ... María J. Crespo in Pharmacological Reports
    Article 20 December 2019
  17. Lacidipine attenuates caffeine-induced anxiety-like symptoms in mice: Role of calcium-induced oxido-nitrosative stress

    Background

    Anxiety is a disorder of multi-factorial pathogenesis involving interrelated pathways of neurotransmitters, oxidative stress and...

    Kunal Khurana, Nitin Bansal in Pharmacological Reports
    Article 26 July 2019
  18. Effects of central RVD-hemopressin(α) administration on anxiety, feeding behavior and hypothalamic neuromodulators in the rat

    Background

    The endocannabinoid (eCB) system is strongly involved in the regulation of anxiety and feeding behavior. RVD-hemopressin(α) [RVD-hp(α)], a...

    Lucia Recinella, Annalisa Chiavaroli, ... Sheila Leone in Pharmacological Reports
    Article 02 February 2018
  19. Angiotensin converting enzyme and neprilysin inhibition alter pain response in dexhamethasone-induced hypertensive rats

    Background

    We hypothesized that renin-angiotensin system and neprilysin (NEP) inhibition can modulate the nociceptive parameters on hypertensive rats....

    Duygun Altıntaş Aykan, Tuba Tulay Koca, ... Nadire Eser in Pharmacological Reports
    Article 10 December 2018
  20. Involvement of hippocampal angiotensin 1 receptors in anxiety-like behaviour of olfactory bulbectomized rats

    Background

    Accumulated evidence suggests that the enhanced brain angiotensin II (Ang II) activity is associated with stress and anxiety.

    ...
    Roman Tashev, Margarita Ivanova in Pharmacological Reports
    Article 08 March 2018
Did you find what you were looking for? Share feedback.